ISSN: 2705-2222
Model: Open Access/Peer Reviewed
DOI: 10.31248/JDPS
Start Year: 2016
Email: jdps@integrityresjournals.org
https://doi.org/10.31248/JDPS2019.028 | Article Number: 0817C90F1 | Vol.5 (1) - August 2021
Received Date: 28 August 2019 | Accepted Date: 03 August 2021 | Published Date: 30 August 2021
Authors: Richard Odunayo Akinyeye* , Adeleke Adebanji Adepoju , Joshua Iseoluwa Orege and Adekunle Theophilus Adegbuyi
Keywords: Drug assay, pharmaceutical analysis, pharmaceutical products, qualitative assessment, quantitative assessment.
Many pharmaceutical products have been reported to be substandard and counterfeit. About 15% of all drugs circulating in some parts of Africa and Asia are believed to be counterfeit, with figures rising to as high as 50%. This study was therefore carried out to assess the quality of five groups of drugs of different brands manufactured by pharmaceutical companies in Nigeria. Qualitative and quantitative analysis were carried out on the drugs using United States, British and Indian Pharmacopoeias. Qualitative analysis investigated includes: friability test, hardness test, disintegration test, dissolution test, pH, and weight uniformity for tablets; specific gravity, flow rate, pH and weight per ml of syrups. The quantitative analysis includes percentage purity and drug assay determination for different constituents using titrimetric, spectrophotometric and high performance liquid chromatographic (HPLC) methods. From the study, it was established that the Nigeria brands of pharmaceutical products sampled generally conformed to the established qualitative and quantitative specifications. There was however a short slight fall in the chromatographic assay for vitamin B6 in the Blood tonic from one company and similarly, the vitamin B1 in the Blood tonic of one company were at variance to those from other companies. The result for the statistical analysis shows that there is uniformity in weight of all tablets analysed and it complies with the specification. Standard pharmaceutical analysis must therefore be regularly carried out on pharmaceutical products before marketing so as to ensure good health, safety, elimination of sub-standard drugs and prevention of over- or under-dosage, which may further affect or cause damage to the health of the users. Consumer’s choice of generics should therefore be based on the analytical results (assay results, bio-pharmaceutical results, and statistical results) of the product and the projected bioequivalence
Akhilesh, K, Santhosh, K, Sanjay, K, Shiva, K., & Shiva, S. (2014). Analysis of seven brands of paracetamol 500 mg tablets used in hyderbad, using ultraviolet spectrophotometric and high performance liquid Chromatography (HPLC) methods. International Journal of Pharmaceutical Science and Research, 5(3), 951-955. | ||||
Ansel, H. C., Popovich, N. G., & Allen, L. V. (1995). Pharmaceutical dosage forms and drug delivery systems. Williams and Wilkins, Sixth Edition. Pp. 182-193. | ||||
British Pharmacopeia (BP) (2002). British Pharmacopeia (Vol I) and Her Majesty's Stationery Office, University Press, Cambridge. | ||||
Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., & White, N. J. (2005). The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Medicine, 2(4), e100. Crossref |
||||
Dulla, O., Sultana, S., & Md. Hosen, S. (2018). In vitro comparative quality evaluation of different brands of esomeprazole tablets available in selected community pharmacies in Dhaka, Bangladesh. BMC Research Notes, 11, Article number 184. Crossref |
||||
European Union (EU) (2004). Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending directive 2001/83/EC on the community code relating to medicinal products for human use. Official Journal of the European Union no. L-136/34, Apr 30. | ||||
Gupta, M. M., & Patel, V. (2013). Formulation and evaluation oral dispersible tablet of cinnarizine. Journal of Drug Delivery and Therapeutics, 3(2), 12-17. Crossref |
||||
Gupta, M. M., & Saini, T. R. (2009). Preformulation parameters characterization to design, development and formulation of vancomycin hydrochloride tablets for psudomembranous colitis. International Journal of Pharmaceutical Research and Delivery, 9(1), 1-7. | ||||
Indian Pharmacopoeia (1996). Ministry of Health & Family Welfare, Controller of Publication, 4th Edition, Government of India. 2, A144-A145. | ||||
Johnston, A., & Holt, D. W. (2014). Substandard drugs: A potential crisis for public health. British Journal of Clinical Pharmacology, 78(2), 218-243. Crossref |
||||
Khar, R. K., Vyas, S. P., Ahmad, J. F., & Jain, K. G. (2013). Lachman/liebermans: The theory and practice of industrial pharmacy. 4th edition. Delhi: CBS Publishers & Distributor. | ||||
King, R. E., & Schwarz, J. B. (1985). Oral solid dosage forms. In: Remingtons Pharmaceutical Sciences. 17th edition, Mack Pub. Co., Easton, Pennyslvania. Pp. 1603-1641. | ||||
Musa, H., Sule, Y. Z. & Gwarzo, M. S. (2011). Assessment of physicochemical properties of Metronidazole tablets marketed in Zaria, Nigeria. International Journal of Pharmacy and Pharmaceutical Sciences, 3(Suppl 3), 27¬-29. | ||||
Racchi, M., Govoni, S., Lucchelli, A., Capone, L., & Giovagnoni, E. (2016). Insights into the definition of terms in European medical device regulation. Expert Review of Medical Devices, 13(10), 907-917. Crossref |
||||
Sarker, R., Rashid, S., Raju, A. A., Rana, M., Karim, M. F. B., Akter, R., Nayem, A., Howlader, A., Ming, L. C., & Ismail, E. (2016). Evaluation of the pharmaceutical quality of different brands of ranitidine tablets manufactured in Bangladesh: A Pharmaceutical and Public Health Prospective, Journal of Applied Pharmaceutical Science, 6(1), 055-061. Crossref |
||||
US Pharmacopoeia (USP) (2014). United States Pharmacopoeia Convention, Thirty Seventh Edition. Pp. 342-351, 1571-1572. | ||||
World Health Organization (WHO) (2007). Quality assurance of pharmaceuticals: A compendium of guidelines and related materials. Good manufacturing practices and inspection. p 2. | ||||
World Health Organization (WHO) (2012). Medicines: Spurious/falsely labelled/falsified counterfeit labelled/falsified/counterfeit (SFFC) medicines. Link |
||||
Yamato, S., Sakai, M., & Shimada, K. (1996). Quantitative analysis of chlorpheniramine maleate in cough and cold drugs by ion-pair high-performance liquid chromatography for the simultaneous determination of chlorpheniramine and maleate. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan, 116(4), 329-334. Crossref |